BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29779853)

  • 21. CRISPR-Cas9: from Genome Editing to Cancer Research.
    Chen S; Sun H; Miao K; Deng CX
    Int J Biol Sci; 2016; 12(12):1427-1436. PubMed ID: 27994508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [CRISPR/Cas: technique to repair DNA errors: is a clinical breakthrough near?].
    van de Vrugt HJ; Cornel MC; Wolthuis RMF
    Ned Tijdschr Geneeskd; 2018 Jun; 162():. PubMed ID: 30040285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis and therapy with CRISPR advanced CRISPR based tools for point of care diagnostics and early therapies.
    Uppada V; Gokara M; Rasineni GK
    Gene; 2018 May; 656():22-29. PubMed ID: 29496558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient single-copy HDR by 5' modified long dsDNA donors.
    Gutierrez-Triana JA; Tavhelidse T; Thumberger T; Thomas I; Wittbrodt B; Kellner T; Anlas K; Tsingos E; Wittbrodt J
    Elife; 2018 Aug; 7():. PubMed ID: 30156184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA Editing for Amyotrophic Lateral Sclerosis: Leading Off First Base.
    Cunningham TJ; Fisher E; Fratta P; Gilthorpe JD
    CRISPR J; 2020 Apr; 3(2):75-77. PubMed ID: 32315228
    [No Abstract]   [Full Text] [Related]  

  • 26. Repair of a Site-Specific DNA Cleavage: Old-School Lessons for Cas9-Mediated Gene Editing.
    Gallagher DN; Haber JE
    ACS Chem Biol; 2018 Feb; 13(2):397-405. PubMed ID: 29083855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene editing using CRISPR-Cas9 for the treatment of lung cancer.
    Castillo A
    Colomb Med (Cali); 2016 Dec; 47(4):178-180. PubMed ID: 28293040
    [No Abstract]   [Full Text] [Related]  

  • 28. Increasing the efficiency of CRISPR/Cas9-mediated precise genome editing in rats by inhibiting NHEJ and using Cas9 protein.
    Ma Y; Chen W; Zhang X; Yu L; Dong W; Pan S; Gao S; Huang X; Zhang L
    RNA Biol; 2016 Jul; 13(7):605-12. PubMed ID: 27163284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [CRISPR-Cas system as molecular scissors for gene therapy].
    Heinz GA; Mashreghi MF
    Z Rheumatol; 2017 Feb; 76(1):46-49. PubMed ID: 28124743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging Role of CRISPR/Cas9 Technology for MicroRNAs Editing in Cancer Research.
    Aquino-Jarquin G
    Cancer Res; 2017 Dec; 77(24):6812-6817. PubMed ID: 29208606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A new milestone in human embryo editing].
    Jordan B
    Med Sci (Paris); 2017 May; 33(5):549-554. PubMed ID: 28612733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRISPR/Cas9-mediated correction of human genetic disease.
    Men K; Duan X; He Z; Yang Y; Yao S; Wei Y
    Sci China Life Sci; 2017 May; 60(5):447-457. PubMed ID: 28534256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How genome editing could be used in the treatment of cardiovascular diseases.
    Musunuru K
    Per Med; 2018 Mar; 15(2):67-69. PubMed ID: 29714123
    [No Abstract]   [Full Text] [Related]  

  • 34. Communicating Biotech Advances: Fiction versus Reality.
    MaƂyska A; Bolla R; Twardowski T
    Trends Biotechnol; 2018 Feb; 36(2):121-123. PubMed ID: 29174176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The CRISPR/Cas9 Genome Editing Revolution.
    Jiao R; Gao C
    J Genet Genomics; 2016 May; 43(5):227-8. PubMed ID: 27256542
    [No Abstract]   [Full Text] [Related]  

  • 36. New horizons in reproductive biology: a special issue.
    Yan W; Clarke H
    Biol Reprod; 2019 Sep; 101(3):513. PubMed ID: 31350845
    [No Abstract]   [Full Text] [Related]  

  • 37. The ethics of creating genetically modified children using genome editing.
    Ishii T
    Curr Opin Endocrinol Diabetes Obes; 2017 Dec; 24(6):418-423. PubMed ID: 28885275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges.
    Mout R; Ray M; Lee YW; Scaletti F; Rotello VM
    Bioconjug Chem; 2017 Apr; 28(4):880-884. PubMed ID: 28263568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
    Doetschman T; Georgieva T
    Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRISPR/Cas9 Technology as an Emerging Tool for Targeting Amyotrophic Lateral Sclerosis (ALS).
    Kruminis-Kaszkiel E; Juranek J; Maksymowicz W; Wojtkiewicz J
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.